# Prognostic Value of 177Lutetium-PSMA Single Photon Emission Tomography and Timing of Response

> **NCT07643935** · — · NOT_YET_RECRUITING · sponsor: **Central Hospital, Nancy, France** · enrollment: 280 (estimated)

## Conditions studied

- Therapy-Associated Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07643935
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2026-09-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2026-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07643935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07643935, "Prognostic Value of 177Lutetium-PSMA Single Photon Emission Tomography and Timing of Response". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07643935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*